Menlo Park, CA, United States of America

Rudy Schreiber

USPTO Granted Patents = 17 



Average Co-Inventor Count = 9.5

ph-index = 8

Forward Citations = 128(Granted Patents)


Location History:

  • Köln, DE (2002 - 2004)
  • Mountain View, CA (US) (2006)
  • Watertown, MA (US) (2014 - 2017)
  • Menlo Park, CA (US) (2006 - 2019)

Company Filing History:


Years Active: 2002-2019

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):

Title: **Innovator Spotlight: Rudy Schreiber**

Introduction

Rudy Schreiber is a notable inventor based in Watertown, Massachusetts, who has made significant contributions to the field of neuroscience through his innovative work. With a total of two patents to his name, Schreiber's inventions showcase his dedication to advancing medical treatments, particularly in the realm of neurological disorders.

Latest Patents

Schreiber's most recent patents focus on "Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors." These include the phenyl-substituted cyclohexylamine derivatives and methods for their synthesis and characterization. The compounds developed through his research aim to treat and prevent various neurological disorders by inhibiting the reuptake of endogenous monoamines such as dopamine, serotonin, and norepinephrine. Moreover, the invention provides formulations that incorporate these compounds, enhancing their potential for effective therapeutic applications.

Career Highlights

Throughout his career, Rudy Schreiber has been associated with Sunovion Pharmaceuticals Inc., a company widely recognized for its commitment to innovative therapies in mental health and neurological conditions. His work in developing novel compounds demonstrates an intersection of scientific research and practical application, contributing to advancements that may improve patient outcomes.

Collaborations

In his journey of innovation, Schreiber has collaborated with esteemed colleagues, including Liming Shao and Fengjiang Wang. These collaborations underline the importance of teamwork in research and development, paving the way for significant breakthroughs in pharmaceuticals.

Conclusion

Rudy Schreiber exemplifies the spirit of innovation through his dedicated work on monoamine reuptake inhibitors. His contributions, particularly in treating neurological disorders, highlight the vital role of inventors in advancing science and improving health outcomes. As he continues his work in the dynamic environment of Sunovion Pharmaceuticals Inc., the potential for further impactful inventions remains high.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…